Loading…
Outcomes and Management of Patients with Cushing’s Disease without Pathological Confirmation of Tumor Resection after Transsphenoidal Surgery
Context: Despite the success of transsphenoidal surgery (TSS) for the treatment of Cushing’s disease, in a number of cases, an ACTH-staining pituitary adenoma is not identified histologically. The clinical significance of lack of histological confirmation remains unclear. Setting: This was a retrosp...
Saved in:
Published in: | The journal of clinical endocrinology and metabolism 2007-09, Vol.92 (9), p.3383-3388 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c401t-f6a9b7791ed81e5b803cf70e9655574535d721e44b59b280814ffacacb436e33 |
---|---|
cites | cdi_FETCH-LOGICAL-c401t-f6a9b7791ed81e5b803cf70e9655574535d721e44b59b280814ffacacb436e33 |
container_end_page | 3388 |
container_issue | 9 |
container_start_page | 3383 |
container_title | The journal of clinical endocrinology and metabolism |
container_volume | 92 |
creator | Pouratian, Nader Prevedello, Daniel M. Jagannathan, Jay Lopes, M. Beatriz Vance, Mary Lee Laws, Edward R. |
description | Context: Despite the success of transsphenoidal surgery (TSS) for the treatment of Cushing’s disease, in a number of cases, an ACTH-staining pituitary adenoma is not identified histologically. The clinical significance of lack of histological confirmation remains unclear.
Setting: This was a retrospective review of patients treated at the University of Virginia Medical Center.
Patients: Of 490 TSS procedures for Cushing’s disease between 1993 and 2004, we identified 111 cases without histological adenoma confirmation.
Main Outcome Measure: Remission and recurrence of Cushing’s disease were measured.
Results: Overall, 50% of these patients achieved remission, a figure lower than for our entire series (79%) and for patients with histological confirmation of an ACTH-staining adenoma (88%) (P < 0.001). Patients with a history of two prior TSS achieved remission less often than patients with a history of fewer TSS (P = 0.026). No other factors influenced remission rates. Although the overall recurrence rate (21%, seven of 33 evaluated) was not different from previously published long-term studies, in three of seven cases of recurrence, early recurrences were noted between 2 and 4 months after remission. In patients who did not achieve remission, the most common and effective treatment options were repeat TSS, γ-knife radiosurgery, and bilateral adrenalectomy.
Conclusion: The lower remission rate in patients without histological evidence of an adenoma is most likely a result of a decreased rate of adenoma extirpation. The incidence of early recurrence may be a unique feature of this patient population; patients without histological confirmation of tumor resection therefore require close and consistent monitoring postoperatively. |
doi_str_mv | 10.1210/jc.2007-0208 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68244352</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68244352</sourcerecordid><originalsourceid>FETCH-LOGICAL-c401t-f6a9b7791ed81e5b803cf70e9655574535d721e44b59b280814ffacacb436e33</originalsourceid><addsrcrecordid>eNptkM9u1DAQhy0EotvCjXPlC5yaYjv2OjmiLf-koiLYA7fIcca7XiX21pMI7Y034Mzr8SQ43ZV64eSR_c1vPB8hrzi75oKztzt7LRjTBROsekIWvJaq0LzWT8mCMcGLWosfZ-QccccYl1KVz8kZ16pWQokF-X03jTYOgNSEjn4xwWxggDDS6OhXM_pcIv3pxy1dTbj1YfP31x-kNx7BIDw8xGmcyW3s48Zb09NVDM6nITfHMMespyEm-g0Q7MOVcSMkuk4mIO63EKLvctf3KW0gHV6QZ870CC9P5wVZf3i_Xn0qbu8-fl69uy2sZHws3NLUrdY1h67ioNqKldZpBvVSKaXzkqrTgoOUrapbUbGKS-eMNbaV5RLK8oK8OcbuU7yfAMdm8Gih702AOGGzrISUpRIZvDqCNkXEBK7ZJz-YdGg4a2b_zc42s_9m9p_xy1Pu1A7QPcIn4Rl4fQIMZlkuW7AeH7k6f1VXKnPlkYPQRZt8gH0CxGYXpxSymP-P_wf5KqJ8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68244352</pqid></control><display><type>article</type><title>Outcomes and Management of Patients with Cushing’s Disease without Pathological Confirmation of Tumor Resection after Transsphenoidal Surgery</title><source>Oxford University Press:Jisc Collections:OUP Read and Publish 2024-2025 (2024 collection) (Reading list)</source><creator>Pouratian, Nader ; Prevedello, Daniel M. ; Jagannathan, Jay ; Lopes, M. Beatriz ; Vance, Mary Lee ; Laws, Edward R.</creator><creatorcontrib>Pouratian, Nader ; Prevedello, Daniel M. ; Jagannathan, Jay ; Lopes, M. Beatriz ; Vance, Mary Lee ; Laws, Edward R.</creatorcontrib><description>Context: Despite the success of transsphenoidal surgery (TSS) for the treatment of Cushing’s disease, in a number of cases, an ACTH-staining pituitary adenoma is not identified histologically. The clinical significance of lack of histological confirmation remains unclear.
Setting: This was a retrospective review of patients treated at the University of Virginia Medical Center.
Patients: Of 490 TSS procedures for Cushing’s disease between 1993 and 2004, we identified 111 cases without histological adenoma confirmation.
Main Outcome Measure: Remission and recurrence of Cushing’s disease were measured.
Results: Overall, 50% of these patients achieved remission, a figure lower than for our entire series (79%) and for patients with histological confirmation of an ACTH-staining adenoma (88%) (P < 0.001). Patients with a history of two prior TSS achieved remission less often than patients with a history of fewer TSS (P = 0.026). No other factors influenced remission rates. Although the overall recurrence rate (21%, seven of 33 evaluated) was not different from previously published long-term studies, in three of seven cases of recurrence, early recurrences were noted between 2 and 4 months after remission. In patients who did not achieve remission, the most common and effective treatment options were repeat TSS, γ-knife radiosurgery, and bilateral adrenalectomy.
Conclusion: The lower remission rate in patients without histological evidence of an adenoma is most likely a result of a decreased rate of adenoma extirpation. The incidence of early recurrence may be a unique feature of this patient population; patients without histological confirmation of tumor resection therefore require close and consistent monitoring postoperatively.</description><identifier>ISSN: 0021-972X</identifier><identifier>EISSN: 1945-7197</identifier><identifier>DOI: 10.1210/jc.2007-0208</identifier><identifier>PMID: 17595252</identifier><identifier>CODEN: JCEMAZ</identifier><language>eng</language><publisher>Bethesda, MD: Endocrine Society</publisher><subject>ACTH-Secreting Pituitary Adenoma - diagnosis ; ACTH-Secreting Pituitary Adenoma - pathology ; ACTH-Secreting Pituitary Adenoma - surgery ; Adenoma - diagnosis ; Adenoma - pathology ; Adenoma - surgery ; Adolescent ; Adrenals. Adrenal axis. Renin-angiotensin system (diseases) ; Adult ; Aged ; Biological and medical sciences ; Child ; Endocrinopathies ; Feeding. Feeding behavior ; Female ; Fundamental and applied biological sciences. Psychology ; Humans ; Male ; Medical sciences ; Middle Aged ; Neoplasm Recurrence, Local - diagnosis ; Neoplasm Recurrence, Local - pathology ; Neoplasm, Residual ; Non tumoral diseases. Target tissue resistance. Benign neoplasms ; Pituitary ACTH Hypersecretion - diagnosis ; Pituitary ACTH Hypersecretion - pathology ; Pituitary ACTH Hypersecretion - surgery ; Prognosis ; Remission Induction ; Retrospective Studies ; Treatment Failure ; Treatment Outcome ; Vertebrates: anatomy and physiology, studies on body, several organs or systems ; Vertebrates: endocrinology</subject><ispartof>The journal of clinical endocrinology and metabolism, 2007-09, Vol.92 (9), p.3383-3388</ispartof><rights>2007 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c401t-f6a9b7791ed81e5b803cf70e9655574535d721e44b59b280814ffacacb436e33</citedby><cites>FETCH-LOGICAL-c401t-f6a9b7791ed81e5b803cf70e9655574535d721e44b59b280814ffacacb436e33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=19081785$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17595252$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pouratian, Nader</creatorcontrib><creatorcontrib>Prevedello, Daniel M.</creatorcontrib><creatorcontrib>Jagannathan, Jay</creatorcontrib><creatorcontrib>Lopes, M. Beatriz</creatorcontrib><creatorcontrib>Vance, Mary Lee</creatorcontrib><creatorcontrib>Laws, Edward R.</creatorcontrib><title>Outcomes and Management of Patients with Cushing’s Disease without Pathological Confirmation of Tumor Resection after Transsphenoidal Surgery</title><title>The journal of clinical endocrinology and metabolism</title><addtitle>J Clin Endocrinol Metab</addtitle><description>Context: Despite the success of transsphenoidal surgery (TSS) for the treatment of Cushing’s disease, in a number of cases, an ACTH-staining pituitary adenoma is not identified histologically. The clinical significance of lack of histological confirmation remains unclear.
Setting: This was a retrospective review of patients treated at the University of Virginia Medical Center.
Patients: Of 490 TSS procedures for Cushing’s disease between 1993 and 2004, we identified 111 cases without histological adenoma confirmation.
Main Outcome Measure: Remission and recurrence of Cushing’s disease were measured.
Results: Overall, 50% of these patients achieved remission, a figure lower than for our entire series (79%) and for patients with histological confirmation of an ACTH-staining adenoma (88%) (P < 0.001). Patients with a history of two prior TSS achieved remission less often than patients with a history of fewer TSS (P = 0.026). No other factors influenced remission rates. Although the overall recurrence rate (21%, seven of 33 evaluated) was not different from previously published long-term studies, in three of seven cases of recurrence, early recurrences were noted between 2 and 4 months after remission. In patients who did not achieve remission, the most common and effective treatment options were repeat TSS, γ-knife radiosurgery, and bilateral adrenalectomy.
Conclusion: The lower remission rate in patients without histological evidence of an adenoma is most likely a result of a decreased rate of adenoma extirpation. The incidence of early recurrence may be a unique feature of this patient population; patients without histological confirmation of tumor resection therefore require close and consistent monitoring postoperatively.</description><subject>ACTH-Secreting Pituitary Adenoma - diagnosis</subject><subject>ACTH-Secreting Pituitary Adenoma - pathology</subject><subject>ACTH-Secreting Pituitary Adenoma - surgery</subject><subject>Adenoma - diagnosis</subject><subject>Adenoma - pathology</subject><subject>Adenoma - surgery</subject><subject>Adolescent</subject><subject>Adrenals. Adrenal axis. Renin-angiotensin system (diseases)</subject><subject>Adult</subject><subject>Aged</subject><subject>Biological and medical sciences</subject><subject>Child</subject><subject>Endocrinopathies</subject><subject>Feeding. Feeding behavior</subject><subject>Female</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Neoplasm Recurrence, Local - diagnosis</subject><subject>Neoplasm Recurrence, Local - pathology</subject><subject>Neoplasm, Residual</subject><subject>Non tumoral diseases. Target tissue resistance. Benign neoplasms</subject><subject>Pituitary ACTH Hypersecretion - diagnosis</subject><subject>Pituitary ACTH Hypersecretion - pathology</subject><subject>Pituitary ACTH Hypersecretion - surgery</subject><subject>Prognosis</subject><subject>Remission Induction</subject><subject>Retrospective Studies</subject><subject>Treatment Failure</subject><subject>Treatment Outcome</subject><subject>Vertebrates: anatomy and physiology, studies on body, several organs or systems</subject><subject>Vertebrates: endocrinology</subject><issn>0021-972X</issn><issn>1945-7197</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><recordid>eNptkM9u1DAQhy0EotvCjXPlC5yaYjv2OjmiLf-koiLYA7fIcca7XiX21pMI7Y034Mzr8SQ43ZV64eSR_c1vPB8hrzi75oKztzt7LRjTBROsekIWvJaq0LzWT8mCMcGLWosfZ-QccccYl1KVz8kZ16pWQokF-X03jTYOgNSEjn4xwWxggDDS6OhXM_pcIv3pxy1dTbj1YfP31x-kNx7BIDw8xGmcyW3s48Zb09NVDM6nITfHMMespyEm-g0Q7MOVcSMkuk4mIO63EKLvctf3KW0gHV6QZ870CC9P5wVZf3i_Xn0qbu8-fl69uy2sZHws3NLUrdY1h67ioNqKldZpBvVSKaXzkqrTgoOUrapbUbGKS-eMNbaV5RLK8oK8OcbuU7yfAMdm8Gih702AOGGzrISUpRIZvDqCNkXEBK7ZJz-YdGg4a2b_zc42s_9m9p_xy1Pu1A7QPcIn4Rl4fQIMZlkuW7AeH7k6f1VXKnPlkYPQRZt8gH0CxGYXpxSymP-P_wf5KqJ8</recordid><startdate>20070901</startdate><enddate>20070901</enddate><creator>Pouratian, Nader</creator><creator>Prevedello, Daniel M.</creator><creator>Jagannathan, Jay</creator><creator>Lopes, M. Beatriz</creator><creator>Vance, Mary Lee</creator><creator>Laws, Edward R.</creator><general>Endocrine Society</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20070901</creationdate><title>Outcomes and Management of Patients with Cushing’s Disease without Pathological Confirmation of Tumor Resection after Transsphenoidal Surgery</title><author>Pouratian, Nader ; Prevedello, Daniel M. ; Jagannathan, Jay ; Lopes, M. Beatriz ; Vance, Mary Lee ; Laws, Edward R.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c401t-f6a9b7791ed81e5b803cf70e9655574535d721e44b59b280814ffacacb436e33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>ACTH-Secreting Pituitary Adenoma - diagnosis</topic><topic>ACTH-Secreting Pituitary Adenoma - pathology</topic><topic>ACTH-Secreting Pituitary Adenoma - surgery</topic><topic>Adenoma - diagnosis</topic><topic>Adenoma - pathology</topic><topic>Adenoma - surgery</topic><topic>Adolescent</topic><topic>Adrenals. Adrenal axis. Renin-angiotensin system (diseases)</topic><topic>Adult</topic><topic>Aged</topic><topic>Biological and medical sciences</topic><topic>Child</topic><topic>Endocrinopathies</topic><topic>Feeding. Feeding behavior</topic><topic>Female</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Neoplasm Recurrence, Local - diagnosis</topic><topic>Neoplasm Recurrence, Local - pathology</topic><topic>Neoplasm, Residual</topic><topic>Non tumoral diseases. Target tissue resistance. Benign neoplasms</topic><topic>Pituitary ACTH Hypersecretion - diagnosis</topic><topic>Pituitary ACTH Hypersecretion - pathology</topic><topic>Pituitary ACTH Hypersecretion - surgery</topic><topic>Prognosis</topic><topic>Remission Induction</topic><topic>Retrospective Studies</topic><topic>Treatment Failure</topic><topic>Treatment Outcome</topic><topic>Vertebrates: anatomy and physiology, studies on body, several organs or systems</topic><topic>Vertebrates: endocrinology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pouratian, Nader</creatorcontrib><creatorcontrib>Prevedello, Daniel M.</creatorcontrib><creatorcontrib>Jagannathan, Jay</creatorcontrib><creatorcontrib>Lopes, M. Beatriz</creatorcontrib><creatorcontrib>Vance, Mary Lee</creatorcontrib><creatorcontrib>Laws, Edward R.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The journal of clinical endocrinology and metabolism</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pouratian, Nader</au><au>Prevedello, Daniel M.</au><au>Jagannathan, Jay</au><au>Lopes, M. Beatriz</au><au>Vance, Mary Lee</au><au>Laws, Edward R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Outcomes and Management of Patients with Cushing’s Disease without Pathological Confirmation of Tumor Resection after Transsphenoidal Surgery</atitle><jtitle>The journal of clinical endocrinology and metabolism</jtitle><addtitle>J Clin Endocrinol Metab</addtitle><date>2007-09-01</date><risdate>2007</risdate><volume>92</volume><issue>9</issue><spage>3383</spage><epage>3388</epage><pages>3383-3388</pages><issn>0021-972X</issn><eissn>1945-7197</eissn><coden>JCEMAZ</coden><abstract>Context: Despite the success of transsphenoidal surgery (TSS) for the treatment of Cushing’s disease, in a number of cases, an ACTH-staining pituitary adenoma is not identified histologically. The clinical significance of lack of histological confirmation remains unclear.
Setting: This was a retrospective review of patients treated at the University of Virginia Medical Center.
Patients: Of 490 TSS procedures for Cushing’s disease between 1993 and 2004, we identified 111 cases without histological adenoma confirmation.
Main Outcome Measure: Remission and recurrence of Cushing’s disease were measured.
Results: Overall, 50% of these patients achieved remission, a figure lower than for our entire series (79%) and for patients with histological confirmation of an ACTH-staining adenoma (88%) (P < 0.001). Patients with a history of two prior TSS achieved remission less often than patients with a history of fewer TSS (P = 0.026). No other factors influenced remission rates. Although the overall recurrence rate (21%, seven of 33 evaluated) was not different from previously published long-term studies, in three of seven cases of recurrence, early recurrences were noted between 2 and 4 months after remission. In patients who did not achieve remission, the most common and effective treatment options were repeat TSS, γ-knife radiosurgery, and bilateral adrenalectomy.
Conclusion: The lower remission rate in patients without histological evidence of an adenoma is most likely a result of a decreased rate of adenoma extirpation. The incidence of early recurrence may be a unique feature of this patient population; patients without histological confirmation of tumor resection therefore require close and consistent monitoring postoperatively.</abstract><cop>Bethesda, MD</cop><pub>Endocrine Society</pub><pmid>17595252</pmid><doi>10.1210/jc.2007-0208</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0021-972X |
ispartof | The journal of clinical endocrinology and metabolism, 2007-09, Vol.92 (9), p.3383-3388 |
issn | 0021-972X 1945-7197 |
language | eng |
recordid | cdi_proquest_miscellaneous_68244352 |
source | Oxford University Press:Jisc Collections:OUP Read and Publish 2024-2025 (2024 collection) (Reading list) |
subjects | ACTH-Secreting Pituitary Adenoma - diagnosis ACTH-Secreting Pituitary Adenoma - pathology ACTH-Secreting Pituitary Adenoma - surgery Adenoma - diagnosis Adenoma - pathology Adenoma - surgery Adolescent Adrenals. Adrenal axis. Renin-angiotensin system (diseases) Adult Aged Biological and medical sciences Child Endocrinopathies Feeding. Feeding behavior Female Fundamental and applied biological sciences. Psychology Humans Male Medical sciences Middle Aged Neoplasm Recurrence, Local - diagnosis Neoplasm Recurrence, Local - pathology Neoplasm, Residual Non tumoral diseases. Target tissue resistance. Benign neoplasms Pituitary ACTH Hypersecretion - diagnosis Pituitary ACTH Hypersecretion - pathology Pituitary ACTH Hypersecretion - surgery Prognosis Remission Induction Retrospective Studies Treatment Failure Treatment Outcome Vertebrates: anatomy and physiology, studies on body, several organs or systems Vertebrates: endocrinology |
title | Outcomes and Management of Patients with Cushing’s Disease without Pathological Confirmation of Tumor Resection after Transsphenoidal Surgery |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T07%3A19%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Outcomes%20and%20Management%20of%20Patients%20with%20Cushing%E2%80%99s%20Disease%20without%20Pathological%20Confirmation%20of%20Tumor%20Resection%20after%20Transsphenoidal%20Surgery&rft.jtitle=The%20journal%20of%20clinical%20endocrinology%20and%20metabolism&rft.au=Pouratian,%20Nader&rft.date=2007-09-01&rft.volume=92&rft.issue=9&rft.spage=3383&rft.epage=3388&rft.pages=3383-3388&rft.issn=0021-972X&rft.eissn=1945-7197&rft.coden=JCEMAZ&rft_id=info:doi/10.1210/jc.2007-0208&rft_dat=%3Cproquest_cross%3E68244352%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c401t-f6a9b7791ed81e5b803cf70e9655574535d721e44b59b280814ffacacb436e33%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=68244352&rft_id=info:pmid/17595252&rfr_iscdi=true |